IndraLab

Statements

Doxycycline inhibits NFKB1. 4 / 4
| 4
reach
"Doxycycline, as a member of the tetracycline antibiotic family has effective anti-inflammatory attributes along with in-vitro inhibition of MMPs, and reduced activation of the MAPK and NFkB pathways ([MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
33662353
reach
"Doxycycline can inhibit the activation of the MAPK and NFkB pathways and protects the corneal epithelial barrier function and conjunctival goblet cells [XREF_BIBR]."
28661456
reach
"In contrast, NFkB activity was suppressed in both HeLa TET-off and MDR-Off cell lines, suggesting that doxycycline suppresses NFkB activity."
26101157
reach
"In addition, the study demonstrated that doxycycline treatment causes cell cycle arrest and inhibits NFkB and STAT3 signalling, as our experiments show."
26425660